Free public records show Sinovac Biotech Co., Ltd in 10 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Sinovac Biotech Co., Ltd or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
20 active studies led by Sinovac Biotech Co., Ltd, of 95 in all
Source: ClinicalTrials.gov, Studies with Sinovac Biotech Co., Ltd (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Annual reports and other filings with the US Securities and Exchange Commission.
Source: SEC EDGAR, Company filings, CIK 1084201.
Studies Sinovac Biotech Co., Ltd leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Sinovac Biotech Co., Ltd or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Sinovac Biotech Co., Ltd: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Sinovac Biotech Co., Ltd is in.
Stories on the topics Sinovac Biotech Co., Ltd works in.
Seasonal flu causes about a billion cases a year. Vitamin C and zinc can shorten colds a little, but vaccines…
Read
TB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…
Read
Drug-resistant infections already kill over a million people a year. Faster testing helps doctors pick the…
ReadSearch all reports for Sinovac Biotech Co., Ltd All companies